Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Deeren, Dries" or (type any "bookEditor journalEditor issueEditor" and editor="Deeren, Dr...

Add to list
- Journal Article
- A1
- open access
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies

Philippe Decruyenaere (UGent) , Edoardo Giuili, Kimberly Verniers (UGent) , Jasper Anckaert (UGent) , Katrien De Grove (UGent) , Malaïka Van der Linden (UGent) , Dries Deeren, Jo Van Dorpe (UGent) , Fritz Offner (UGent) and Jo Vandesompele (UGent)

(2023) FRONTIERS IN ONCOLOGY. 13.
Add to list
- Journal Article
- A1
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)

Xavier Poire, Carlos Graux, Aurelie Ory, Julie Herman, Frederic Baron, Helene Schoemans, Philippe Lewalle, Ann De Becker, Dries Deeren, Zwi Berneman, et al.

(2022) BONE MARROW TRANSPLANTATION. 57(1). p.116-118
Add to list
- Journal Article
- A1
- open access
Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis : a standardized approach with underappreciated potential

Lennart Raman, Malaïka Van der Linden (UGent) , Ciel De Vriendt (UGent) , Bliede Van den Broeck (UGent) , Kristoff Muylle, Dries Deeren, Franceska Dedeurwaerdere, Sofie Verbeke (UGent) , Amélie Dendooven (UGent) , Katrien De Grove (UGent) , et al.

(2022) HAEMATOLOGICA. 107(1). p.211-220
Add to list
- Journal Article
- A1
- open access
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial

Anita W. Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J. Biemond, Arjen A. van de Loosdrecht, Lotte E. van der Wagen, Mar Bellido, Michel van Gelder, Walter J. F. M. van der Velden, Dominik Selleslag, et al.

(2022) BLOOD ADVANCES. 6(4). p.1115-1125
Add to list
- Journal Article
- A1
Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Anke Delie (UGent) , Anke Verlinden, Karolien Beel, Dries Deeren, Dominiek Mazure (UGent) , Frederic Baron, Dimitri Breems, Ann De Becker, Carlos Graux, Philippe Lewalle, et al.

(2021) ACTA CLINICA BELGICA. 76(6). p.500-508
Add to list
- Journal Article
- A1
- open access
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry

Timothy Devos, Violaine Havelange, Koen Theunissen, Stef Meers, Fleur Samantha Benghiat, Alain Gadisseur, Gaetan Vanstraelen, Helene Vellemans, Benjamin Bailly, Nikki Granacher, et al.

(2021) ANNALS OF HEMATOLOGY. 100(7). p.1723-1732
Add to list
- Journal Article
- A1
Using the World Apheresis Association registry helps to improve the treatment quality of therapeutic apheresis

Bernd Stegmayr, Elizabeth Newman, Volker Witt, Kurt Derfler, Gerda Leitner, Sunny Eloot (UGent) , Annemieke Dhondt (UGent) , Dries Deeren, Jan Ptak, Milan Blaha, et al.

(2021) TRANSFUSION MEDICINE AND HEMOTHERAPY. 48(4). p.234-239
Add to list
- Journal Article
- A1
- open access
Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with AML and high risk MDS

Jeroen Janssen, Bob Lowenberg, Markus Manz, Mario Bargetzi, Bart Biemond, Peter von Dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, et al.

(2021) CANCERS. 13(4).
Add to list
- Journal Article
- A1
- open access
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

Bob Lowenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griskevicius, Lidwine W. Tick, Mojca Jongen-Lavrencic, et al.

(2021) BLOOD ADVANCES. 5(4). p.1110-1121
Add to list
- Conference Paper
- C3
Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring: a standardized approach with underappreciated potential

Malaïka Van der Linden (UGent) , Lennart Raman, Ciel De Vriendt (UGent) , Bliede Van den Broeck (UGent) , Kristoff Muylle, Dries Deeren, Kathleen Claes (UGent) , Björn Menten (UGent) , Fritz Offner (UGent) and Jo Van Dorpe (UGent)

(2020) 35th General Annual Meeting of the Belgian Hematology Society 2020, Abstracts.
Add to list
- Conference Paper
- C3
Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring : a standardized approach with underappreciated potential

Malaïka Van der Linden (UGent) , Lennart Raman, Ciel De Vriendt (UGent) , Bliede Van den Broeck (UGent) , Kristoff Muylle, Dries Deeren, Kathleen Claes (UGent) , Björn Menten (UGent) , Fritz Offner (UGent) and Jo Van Dorpe (UGent)

(2020)
Add to list
- Miscellaneous
Toxoplasma gondii-induced brachial plexus neuropathy after allogeneic hematopoietic stem cell transplantation

Jozefien De Clercq (UGent) , Ilse Crevits, Marijke Reynders and Dries Deeren

(2019) TRANSPLANT INFECTIOUS DISEASE. 21(5).
Add to list
- Journal Article
- A1
Circulating cell-free DNA for response evaluation of intravascular lymphoma

Dries Deeren, Malaïka Van der Linden (UGent) , Franceska Dedeurwaerdere, Lien Deleu, Caressa Meert, Björn Menten (UGent) and Jo Van Dorpe (UGent)

(2019) ANNALS OF HEMATOLOGY. 98(8). p.2021-2023
Add to list
- Conference Paper
- C3
Exploring the potential of shallow whole-genome sequencing for diagnosis and disease monitoring of lymphoma in liquid biopsy

Lennart Raman, Malaïka Van der Linden (UGent) , Ciel De Vriendt (UGent) , Bliede Van den Broeck (UGent) , Kristoff Muylle, Dries Deeren, Björn Menten (UGent) , Fritz Offner (UGent) and Jo Van Dorpe (UGent)

(2019) BLOOD. 134.
Add to list
- Journal Article
- A1
Clinical implications of measurable residual disease in AML : review of current evidence

Ine Moors (UGent) , Karl Vandepoele (UGent) , Jan Philippé (UGent) , Dries Deeren, Dominik Selleslag, Dimitri Breems, Nicole Straetmans, Tessa Kerre (UGent) and Barbara Denys (UGent)

(2019) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 133. p.142-148
Add to list
- Conference Paper
- C3
Ixazomib, Rituximab and Dexamethasone (IRD) in patients with relapsed or progressive Waldenstrom's macroblobulinemia : results of the prospective phase I/II hovon 124/Ecwm-R2 trial

Marie Jose Kersten, Monique C. Minnema, Josephine M. Vos, Kazem Nasserinejad, Marcel Kap, Eftathios Kastritis, Maria Gavriatopoulou, Martine E. D. Chamuleau, Dries Deeren, Lidwine Winnifred, et al.

(2019) BLOOD. 134(Suppl 1).
Add to list
- Journal Article
- A1
Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres

Helene A. Poirel, Marijke Vanspauwen, Gilles Macq, Anke De Geyndt, Johan Maertens, Evelyne Willems, Dominik Selleslag, Xavier Poire, Koen Theunissen, Carlos Graux, et al.

(2019) BONE MARROW TRANSPLANTATION. 54(9). p.1434-1442
Add to list
- Journal Article
- A1
Lymphoplasmacytic lymphoma exposed by haemoptysis and acquired von Willebrand syndrome

Line Coucke, Ludo Marcelis, Dries Deeren, Jo Van Dorpe (UGent) , Kathleen Lambein (UGent) and Katrien Devreese (UGent)

(2014) BLOOD COAGULATION & FIBRINOLYSIS. 25(4). p.395-397
Add to list
- Journal Article
- A1
Clonal multicentric Castleman's disease with increased free kappa light chains in a patient with systemic lupus erythematosus

Matthijs Oyaert, Elke Boone, Liesbeth De Ceuninck, Els Moreau, Jo Van Dorpe (UGent) , Hilde Vanpoucke and Dries Deeren

(2014) ANNALS OF HEMATOLOGY. 93(7). p.1255-1257
Add to list
- Journal Article
- A1
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Michel Delforge, Dominik Selleslag, Yves Beguin, Agnès Triffet, Philippe Mineur, Koen Theunissen, Carlos Graux, Fabienne Trullemans, Dominique Boulet, Koen Van Eygen, et al.

(2014) LEUKEMIA RESEARCH. 38(5). p.557-563
Add to list
- Journal Article
- A1
Effective use of rituximab for acquired amegakaryocytic thrombocytopenia

Dries Deeren and Jo Van Dorpe (UGent)

(2010) AMERICAN JOURNAL OF HEMATOLOGY. 85(12). p.977-978

Academic Bibliography

Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies

Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)

Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis : a standardized approach with underappreciated potential

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial

Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry

Using the World Apheresis Association registry helps to improve the treatment quality of therapeutic apheresis

Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with AML and high risk MDS

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring: a standardized approach with underappreciated potential

Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring : a standardized approach with underappreciated potential

Toxoplasma gondii-induced brachial plexus neuropathy after allogeneic hematopoietic stem cell transplantation

Circulating cell-free DNA for response evaluation of intravascular lymphoma

Exploring the potential of shallow whole-genome sequencing for diagnosis and disease monitoring of lymphoma in liquid biopsy

Clinical implications of measurable residual disease in AML : review of current evidence

Ixazomib, Rituximab and Dexamethasone (IRD) in patients with relapsed or progressive Waldenstrom's macroblobulinemia : results of the prospective phase I/II hovon 124/Ecwm-R2 trial

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres

Lymphoplasmacytic lymphoma exposed by haemoptysis and acquired von Willebrand syndrome

Clonal multicentric Castleman's disease with increased free kappa light chains in a patient with systemic lupus erythematosus

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Effective use of rituximab for acquired amegakaryocytic thrombocytopenia

Contents

Support

Contact